We report on a clinical-genetic study of 16 Wolf-Hirschhorn syndrome (WHS)
patients. Hemizygosity of 4p16.3 was detected by conventional prometaphase
chromosome analysis (11 patients) or by molecular probes on apparently norm
al chromosomes (4 patients), One patient had normal chromosomes without a d
etectable molecular deletion within the WHS "critical region." In each dele
ted patient, the deletion was demonstrated to be terminal by fluorescence i
n situ hybridization (FISH), The proximal breakpoint of the rearrangement w
as established by prometaphase chromosome analysis in cases with a visible
deletion. It was within the 4p16.1 band in six patients, apparently coincid
ent with the distal half of this band in five patients. The extent of each
of the four submicroscopic deletions was established by FISH analyses with
a set of overlapping cosmid clones spanning the 4p16.3 region. We found amp
le variations in both the size of the deletions and the position of the res
pective breakpoints, The precise definition of the cytogenetic defect permi
tted an analysis of the genotype-phenotype correlations in WHS, leading to
the proposal of a set of minimal diagnostic criteria, which in turn may fac
ilitate the selection of critical patients in the search for the gene(s) re
sponsible for this disorder. We observed that genotype-phenotype correlatio
ns in WHS mostly depend on the size of the deletion, a deletion of <3.5 Mb
resulting in a mild phenotype, in which malformations are absent, The absen
ce of a detectable molecular deletion is still consistent with a WHS diagno
sis. Based on these observations a "minimal" WHS phenotype was inferred, th
e clinical manifestations of which are restricted to the typical facial app
earance, mild mental and growth retardation, and congenital hypotonia, (C)
2000 Wiley-Liss, Inc.